JAK is believed to be an essential tyrosine kinase that mediates signals from the cytokine receptor to its downstream events. JAK associates with the cytoplasmic domain of the type I cytokine receptor superfamily and upon the ligand stimulation it can be activated, resulting in the receptor phosphorylation. In signaling from gp130, a common signal transducer for the IL-6 family cytokines, STAT3, a transcription factor that contains an SH2 domain, is recruited by phosphotyrosines on gp130 and is subsequently phosphorylated by gp130-associated JAKs. In this study, we attempted to ®nd a new target for JAK that is directly activated by JAK, independent of gp130 tyrosine phosphorylation, by using a yeast two-hybrid system. In the process we found that the JH2 domain of JAK1, JAK2 or JAK3 could speci®cally associate with the carboxy-terminal portion of STAT5, but not with STAT3 or STAT1. The interaction was con®rmed using both a transient expression system in a cell line and a GST-fusion protein binding assay. Furthermore, we showed that the activation of STAT5 via gp130 did not need any phosphotyrosines on gp130 while that of STAT3 strictly depended on phosphotyrosines on gp130. Mutations of STAT5 that eliminated the interaction with JAK1 reduced the activation of STAT5 upon the gp130 stimulation, although such mutants could be still activated through erythropoietin receptor. These results indicate that STATs are activated through cytokine receptors by two distinct mechanisms, one dependent on receptor tyrosine phosphorylation and the other mediated by the JAK ± STAT direct interaction.
Introduction
Cytokines exhibit functional pleiotrophy and redundancy and play a crucial role in regulating cell growth, dierentiation, and death in various organs (Thomson, 1994) . Molecular cloning of the receptors for cytokines has revealed that they constitute the type I cytokine receptor superfamily (Bazan, 1990; Miyajima et al., 1992) . In contrast to the receptors for growth factors and the TGF-b superfamily, these cytokine receptors do not contain any intrinsic catalytic domain in their cytoplasmic regions (Heldin, 1995) . It has been found that the cytokine receptors constitutively associate with tyrosine kniase JAKs (Janus kinases) (Ziemiecki et al., 1994; Ihle, 1995) and Src-related tyrosine kinases in their cytoplasmic domain (Taniguchi, 1995) . JAK family kinases are thought to be implicated in the activation and tyrosine phosphorylation of various known signaling proteins including signal transducers and activators of transcription (STATs) Ihle, 1996) .
Interleukin-6 (IL-6) and its related cytokine subfamilies including ciliary neurotrophic factor (CNTF), leukemia inhibitory factor (LIF), oncostatin M (OSM), IL-11, and cardiotrophin-1 (CT-1) are typical cytokines that exhibit such functional pleiotrophy and redundancy (Hirano et al., 1986; Sehgel et al., 1989; Hirano and Kishimoto, 1990; Van Snick, 1990; Hirano, 1994; Mackiewicz et al., 1995; Hibi et al., 1996) . The receptor complex for IL-6 is composed of a ligand-binding receptor a-subunit and a signal transducing receptor bsubunit, gp130 (Yamasaki et al., 1988; Taga et al., 1989; Hibi et al., 1990) . The binding of IL-6 to the receptor a-subunit induces the homodimerization of gp130 (Davis et al., 1993; Murakami et al., 1993) , resulting in the clustering and trans-activation of JAKs (JAK1, JAK2, and TYK2), which are constitutively associated with the box 1 region of gp130 (Matsuda et al., 1994; Stahl et al., 1994) . It is thought to be likely that the activated JAKs initiate signal transduction by phosphorylating the downstream signaling molecules including gp130, STATs (STAT3 and STAT1) (Zhong et al., 1994; Akira et al., 1994; Fujitani et al., 1994; Nakajima et al., 1995) , and other molecules Stahl et al., 1995) .
STATs were originally identi®ed as IFN-induced transcription factors by Darnell and his colleagues . To date, seven members of STAT family, six in mammals (STAT1-6) and one in Drosophila (D-STAT), have been identi®ed and characterized. STAT factors play essential roles in a variety of biological functions; STAT1 is critical for interferons (IFNs) to exert their functions, and is also involved in innate immunity (Durbin et al., 1996; Meraz et al., 1996) . STAT6 is essential for IgE class switching and the Th2 response in the immune system (Shimoda et al., 1996; Takeda et al., 1996) . D-STAT regulates the expression of pair rule genes and is critically involved in Drosophila early development (Hou et al., 1996; Yan et al., 1996b) . We have recently shown that STAT3 plays a crucial role in IL-6-induced growth arrest and dierentiation in M1 leukemia cells , and STAT3 is involved in an anti-apoptotic signal from gp130 on BAF-B03 pro-B cells . STAT factors are selectively activated by various cytokine signals. The molecular mechanism by which STATs are selectively activated by individual receptors has already been proposed for the receptor systems of gp130 and others (Greenlund et al., 1994 (Greenlund et al., , 1995 Stahl et al., 1995) . Activated JAK phosphorylates speci®c tyrosine residues on gp130, thereby creating the docking sites for which the SH2 domain of STAT3 can speci®cally recognize; STAT3 activation requires the phosphorylated tyrosine residues ®tting a YXXQ consensus motif located on the distal domain of gp130 (Stahl et al., 1995; Yamanaka et al., 1996) . Similar mechanisms have also been shown for the activation process of other STATs, for example, STAT1 by the INFg receptor (Greenlund et al., 1994) , STAT6 by the IL-4 receptor a chain (Hou et al., 1994) , and STAT5 by the IL-2 receptor b chain and the erythropoietin receptor (Fujii et al., 1995; Friedmann et al., 1996; Gobert et al., 1996; Frederic et al., 1996) . These studies suggest that the activation of STATs strictly depends on the speci®c tyrosine residues on their corresponding receptors, although recent studies have reported that in some cases STATs might be activated independently of the tyrosine residues on the receptors (Mui et al., 1995; Lai et al., 1995; Yoshikawa et al., 1995) . Here we show that STAT5 can be activated independently of tyrosine phosphorylation of gp130 and its activation needs the direct interaction with JAKs. These observations indicate that the activation of STATs involves various mechanisms including the interaction between JAKs and STATs, or STATs and cytokine receptors.
Results

Identi®cation of STAT5 as the binding protein for JAK1, JAK2 and JAK3
To identify proteins that directly interact with JAKs, we employed a yeast two-hybrid screening system using the yeast transcription factor GAL4 (Durfee et al., 1993; Harper et al., 1993) . First we constructed bait plasmids that express entire coding portions of human JAK1 and mouse JAK2 as a fusion protein with the GAL4 DNA binding domain. We then screened a human B cell cDNA library that expressed proteins fused to the GAL4 transcriptional activation domain.
No positive clone, however, was obtained out of one million transformants by screening with JAK1, and two million by JAK2. It is possible that these fulllength proteins, whose molecular weights are approximately 150 kD, are too big or could not display a proper conformation to enter the yeast nucleus. Therefore, we divided the functional domains of JAK1 into three parts, JH7-JH3, JH2, and JH1 ( Figure 1a ) (Harpur et al., 1992) to construct baits. We screened the same library and obtained two clones out of three million transformants, that bound the JH2 domain, whereas we did not obtain any clone that bound to the JH7-JH3 or JH1 domains. The two JH2-binding clones had overlapping sequences and utilized the same reading frame. The nucleotide sequence of the inserts were identical to that of human STAT5b, recently reported (Lin et al., 1996) , which are most homologous to mouse STAT5b (Azam et al., 1995; Mui et al., 1995) . Two forms of mouse and human STAT5 (STAT5a and STAT5b) were reported (Azam et al., 1995; Mui et al., 1995; Hou et al., 1995; Lin et al., 1996) , which have 96% identity at the amino acid level, but they seem to be derived from two dierent genes. The clones obtained from the two-hybrid screening contained the STAT5b fragment from the amino acid 313-(#JH2-21) and 494-(#JH2-14, Figure  1b) .
We determined the speci®city of the interactions using the yeast two-hybrid system (Figure 2a) . All of the JH2 domains of JAK1, JAK2 and JAK3 could interact with either STAT5a or STAT5b, but neither the JH7-JH3 nor the JH1 domain of JAK1, JAK2 and JAK3 could interact with STAT5. This ®nding was consistent with the recent report that JAK3 associates with STAT5 in T lymphocytic leukemia cells (Migone et al., 1995) . On the other hand, the JH2 domains of JAK1, JAK2 and JAK3 could not bind either STAT1 or STAT3, although the levels of expression of STAT1, STAT3 and STAT5a in the yeast nucleus were comparable (Figure 2b ). These data indicate that the JH2 domain of JAK1, JAK2 and JAK3 speci®cally interacts with STAT5a and isolated by the yeast two-hybrid screening. A longer clone (accession number D84466) was obtained from human Jurkat cell cDNA library. Its amino acid sequence was most identical to that of human STAT5b (Lin et al., 1996) with the dierence of two amino acids. The dierence may be due to the dierence of used cDNA source STAT5b. There was no dierence in binding speci®city of STAT5a or STAT5b in the yeast twohybrid system, therefore we used STAT5a for further analysis.
JAK1-STAT5 interaction in vitro and in vivo
To further con®rm the interaction between full-length JAK1 and STAT5a, 293T cells were transiently transfected with the expression vectors for hemagglutinin epitope-tagged JAK1 (HA-JAK1) and Myc epitope-tagged STAT5a (STAT5a-Myc) or Myc epitoped-tagged STAT3 (STAT3-Myc, Figure 3 ). Cells were lysed in lysis buer containing 1% digitonin and extracts were immunoprecipitated by either anti-HA or anti-Myc antibody, then analysed by immunoblotting using either anti-JAK1 or anti-Myc antibody as probe (Figure 3a) . When 293T cells were transfected with the JAK1 expression vector, a large amount of JAK1 was immunoprecipitated with the anti-HA antibody, but JAK1 could not be immunoprecipitated with the antiMyc antibody. When JAK1 and STAT5a were coexpressed, approximately 10% of the JAK1 protein was co-precipitated with the anti-Myc antibody, indicating that JAK1 protein associated with the Myc-tagged STAT5 protein. When JAK1 was coexpressed with STAT5a, about 10% of the STAT5a was also co-immunoprecipitated with JAK1. Unlike STAT5a, STAT3 was not co-immunoprecipitated with JAK1. The interaction between JAK1 and STAT5a was further demonstrated using an in vitro binding assay. The JH2 domains of JAK1 and JAK2 were prepared as GST fusion proteins. STAT protein, which was expressed in 293T cells, was mixed with GST fusion protein-coupled GSH sepharose. The fraction that bound STAT protein was detected by immunoblotting with anti-Myc antibody. As shown in Figure  3b , STAT5a protein speci®cally bound to the JH2 domain of JAK1 or JAK2, but STAT3 protein did not bind to it. The interaction detected by a yeast two-hybrid system. Besides the three fragments of JAK1, the JH2 domains of JAK2 and JAK3 were also used to construct a GAL4 DBD fusion vector. Clone #JH2-14 was used for STAT5b. Corresponding regions in human STAT5a (Hou et al., 1995) , mouse STAT3, and STAT1 were used to construct a GAL4 transactivation domain (ACT) plasmid. Yeast Y190 cells, which harbor GAL4-dependent HIS3 and b-galactosidase reporter genes integrated in their genome, were transformed with the combinations of GAL4 DBD and GAL4 ACT vectors, as indicated. Four independent transformant colonies were picked up and restreaked on synthetic dextrose agar plates lacking uracil (for the b-galactosidase reporter gene), tryptophan (for GAL4 DBD vector), and leucine (for GAL4 ACT vector). Their bgalactosidase activities were examined using an X-gal ®lter assay. The strength of the b-galactosidase activity was indicated as (+++) for the appearance of blue color within 30 min, (++) for within 2 h, (+) for within 6 h and (7) for lack of color development at the 24 h time point. (b) The expression of STAT1, STAT3, and STAT5a in the yeast nucleus. The nuclear extract was isolated from 1610 7 yeast cells transformed with the GAL4 ACT vector of STAT1, STAT3, or STAT5a, which were used in the yeast two-hybrid assay, were separated by the SDS ± PAGE. Their expression was detected by immunoblotting with anti-HA antibody, which recognized the HA-epitope resides between the GAL4 transactivation domain and STAT proteins αM αM αHA αM αHA αM αHA αHA αJ1 αJ1 αJ1 αJ1 αM αM αM αM
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It has been reported that IL-6 can activate STAT5 in addition to STAT1 and STAT3 (Lai et al., 1995; Ripperger et al., 1995) . Using a transient expression system in COS-1 cells, it was revealed that a mutant of gp130 that lacks the YXXQ STAT3 activation motif, can still activate STAT5, suggesting a dierence in the activation mechanisms of STAT3 and STAT5 (Lai et al., 1995) . The direct interaction of JAK1 with STAT5, but not STAT3, detected in both yeast and 293T cells might explain the dierences in their activation mechanisms. To examine this possibility, we ®rst analysed the activation of STAT5 through gp130 in a mouse IL-3-dependent pro-B cell line, BAF-B03, which was stably transfected with G-CSF receptor-gp130 chimeric receptors ( Figure 4a ). The chimeric receptor was composed of the extracellular domain of the human G-CSF receptor, and the transmembrane and cytoplasmic domains of gp130 (G-277). We also constructed a mutant with point mutations (G-Fall), in which all six tyrosines in the cytoplasmic domain of gp130 were mutated to phenylalanines, and a truncation mutant (G-68) , in which the cytoplasmic domain was truncated at the amino acid 68 residues from the membrane. G-68 had the box 1 and box 2 motifs and could activate JAKs (Fukada et al. unpublished data) upon stimulation with G-CSF. We established stable transfectants expressing G-277, G-68, and G-Fall chimeric receptors. G-277 transfectants could proliferate in response to human G-CSF . These transfectants were stimulated with either G-CSF or IL-3, then the tyrosine phosphorylation of endogenous STAT3 and STAT5 was examined. As shown in Figure 4b and c, STAT3 was tyrosine-phosphorylated in G-277 transfectants but , and G-Fall (c). Stable transfectants were established and stimulated either with 100 ng/ml of G-CSF or with IL-3 for 15 min, or left unstimulated (7). 10% conditioned medium from WEHI-3B cells was used as the source for IL-3. After stimulation, STAT5 or STAT3 was immunoprecipitated with anti-STAT5 or anti-STAT3 antibody, respectively. Their expression and tyrosine phosphorylation were detected by immunoblotting with either anti-STAT5, anti-STAT3, or antiphosphotyrosine antibody. (d) Induction of the DNA binding of STAT5 does not depend on the tyrosine residues of gp130. 293T cells were transfected with expression vectors for the combinations, STAT5-Myc/HA-STAT3 and G-277/G-Fall. Seventy-two hours after transfection, cells were either stimulated with 100 ng/ml of G-CSF for 15 min or left unstimulated. Nuclear extracts were prepared from these cells and their DNA binding activity was determined by electrophoretic mobility shift assay using TB-2 as a probe not in G-68 or G-Fall transfectants, consistent with the fact that G-68 or G-Fall does not contain the critical tyrosine residues recognized by the SH2 domain of STAT3 (Y126, Y173, Y262 and Y274) (Stahl et al., 1995; Yamanaka et al., 1996) . In contrast, STAT5 was phosphorylated in G-68 or G-Fall transfectants at similar levels as in G-277 transfectants, consistent with the idea that STAT5 may be activated through the direct interaction with JAK.
These results were further con®rmed in the following transient expression system, using 293T cells. The expression vector for the G-277 or the G-Fall chimeric receptor was co-transfected in 293T cells with either the STAT5 or the STAT3 expression vector. The activation of STAT5 and STAT3 by G-CSF stimulation was examined by an electrophoretic mobility shift assay using as a probe, TB-2 (Lai et al., 1995) , which contains two IL-6RE sequences (APRE) of the rat a2-macroglobulin gene (Figure 4d ). This sequence has been shown to be recognized by both STAT5 and STAT3 (Lai et al., 1995; Mui et al., 1995) . The binding activity of STAT5 to TB-2 was induced through G-Fall as well as through G-277 in response to G-CSF. However, the activation of STAT3 was not observed through G-Fall. Taken together, these results clearly show that the activation of STAT5, unlike that of STAT3, did not require any phosphorylated tyrosine residues on the cytoplasmic domain of gp130.
Determination of binding regions on JAK1 and STAT5
To characterize the association of JAK1 with STAT5 and clarify the role of their interaction in the activation of STAT5, we determined the binding regions on both JAK1 and STAT5 using deletion and point mutants in the yeast two-hybrid system. First, we prepared progressive deletion mutants of the JH2 domain of JAK1 from the carboxy terminus. Using these mutants, we found that the region containing amino acids 568 ± 649, corresponding to the kinase sub-domain I ± IV (Hanks et al., 1988) in JH2, was sucient for binding ( Figure 5a ). The shorter clone (#JH2-14), which we obtained from the yeast two-hybrid screening, contained the SH3 and SH2 domains, as well as the carboxy terminal domain that includes a phosphoacceptor site for JAK1 (Figure 1b) . Carboxy terminal deletions using human STAT5 revealed that amino acids 494 ± 688 comprised a minimal region required for binding (Figure 5b) . Interestingly, deletion of the Y694-containing region did not aect binding, indicating that Y694, a major phosphoacceptor site for JAK (Gouilleux et al., 1994) , is not necessary for at least the binding of JAK1 to STAT5. Further deletion to amino acid 679 abolished the binding with JAK1. Therefore, it was proposed that there must be some critical amino acid residues regulating the association with JAK1 in the amino acid 680 ± 688 region of STAT5. We randomly mutated amino acids in this region to alanines and obtained two mutants, ), with reduced anities to JAK1. In the yeast twohybrid system, these mutants had dierent b-galactosidase (LacZ) activities, indicating dierent strengths of their interactions. With the combination of wild type JAK1 and STAT5a, yeast cells generated 80 units/ml of LacZ activity, which was stronger than that generated by the interaction of p53 and SV40 T antigen (30 ± 40 units/ml, data not shown). The yeast transformants with the ST5(AY) and ST5(AA) mutants produced 12 units/ml and 3 units/ml of LacZ activity, a b Figure 5 Binding regions responsible for the interaction. (a) A binding region on the JH2 domain of JAK1 for STAT5a. Various carboxy terminal truncation mutants of the JH2 domain of JAK1 were constructed in the GAL4 DBD vector. They were transformed in Y190 cells with the STAT5a fragment (the same vector as used in Figure 2 ) in the GAL4 ACT vector. The associations were determined by X-gal ®lter assay as described in Figure 1 . Roman numerals on the schemes indicate domains conserved among protein kinases; these numbers have been denominated as described previously (Hanks et al., 1988) . ( . Various indicated fragments were inserted into the GAL4 ACT vector. They were transformed into Y190 yeast cells with the JAK1-JH2 plasmid in the GAL4 DBD. Their interactions were determined by the X-gal ®lter assay. Three plus (+++) represents blue color development within 30 min, plus (+) for within 6 h and minus (7) indicates a lack of color development assessed at 24 h time point. Tyrosine 682 was mutated to alanine in the ST5(AY) mutant, and both tyrosines 682 and 683 were mutated to alanines in the ST5(AA) mutant. Fragments (corresponding to amino acids 494 ± 794) containing these mutants were constructed in the GAL4 ACT vector and transformed in Y190 cells with the GAL4 DBD-JAK1-JH2 plasmid. The interaction between JAK1-SH2 and either STAT5a or its mutants was determined by liquid b-galactosidase assay using ONPG as a substrate, and indicated as units/ml respectively, indicating that these tyrosine residues have a role in the interaction between JAK1 and STAT5.
Activation of STAT5 was dependent on the interaction of JAK1-JH2 and STAT5
By using the ST5(AY) and ST5(AA) mutants, the functional signi®cance of the JAK-STAT5 direct interaction in vivo was examined (Figure 6 ). Mammalian expression plasmids encoding the ST5(AY) and ST5(AA) mutations were prepared by introducing the same mutations into full-length Myc-tagged STAT5a. 293T cells were transfected with the expression vectors for the STAT5 mutants and the chimeric receptor G-277, and stimulated with G-CSF. The activation of the mutant STAT5s by G-CSF stimulation was evaluated either by an electrophoretic mobility shift assay or by immunoblotting with anti-phosphotyrosine antibody. The induction of the binding activity of STAT5 to TB-2 in response to G-CSF was markedly reduced in the ST5(AY) mutant, and almost abolished in the ST5(AA) mutant (Figure 6a) , although the expression level of STAT5 in each mutant was comparable to that of wild type STAT5 (Figure 6b ). The DNA binding activity of these mutants and wild type STAT5a correlated with the strength of their interactions with JAK1, as detected in the two-hybrid system. The degree of tyrosine phosphorylation of these mutants also correlated with the strength of their interaction with JAK1 (Figure 6b ). To exclude the possibility that these mutants do not exhibit proper conformation as substrates for JAKs, we transfected 293T cells with the expression vectors for these mutants together with mouse erythropoietin (Epo) receptor, and stimulated them with erythropoietin. The activation of STAT5 through the Epo receptor was reported to mainly depend on tyrosine phosphorylation of the receptor. As shown in Figure 6c , both ST5(AY) and ST5(AA) mutants were tyrosine phosphorylated in response to erythropoietin, with slight reduction compared to the wild type, indicating these mutants can be phosphorylated by JAKs in the receptor phosphorylationdependent manner.
These mutant experiments clearly demonstrate a critical role for the JAK-STAT5 direct interaction in tyrosine phosphorylation and the activation of STAT5 in the gp130 system.
Discussion
Direct binding of STAT5 with JAK through the JH2 domain
Among the conserved domains of JAK family kinases, JH1, located in the carboxy terminus, has all the conserved features of a tyrosine kinase. The JH1 domain has been shown to possess tyrosine kinase activity when expressed in bacterial cells as a fusion protein. In contrast, the JH2 domain has no detectable kinase activity for any known exogenous substrates when it is expressed in bacteria (Wilks et al., 1991) . Interestingly, deletion of the JH2 domain of Tyk2 does not abolish the autophosphorylation of Tyk2 itself, but The tyrosine phosphorylation and expression of STAT5 proteins were detected by immunoblotting, as described above eliminates its phosphotransfer activity for an exogenous substrate such as enolase (Velazquez et al., 1995) , suggesting that the JH2 domain might determine the substrate speci®city for JAKs. In this report, we identi®ed the JH2 domains of JAK1, JAK2 and JAK3 as binding regions for STAT5s. The interaction between kinases and their substrates has been detected in a two-hybrid system or in vitro for various serine/ threonine kinases (Yang et al., 1992; Elion et al., 1993; Hibi et al., 1993) . Structural analysis of serine/ threonine protein kinases such as protein kinase A, MAP kinase ERK, and cell cycle-dependent kinase cdk2 has revealed that they have a substrate pocket in their carboxy terminal region, which recognize and bind their substrate at least transiently (Knighton et al., 1991; De Bondt et al., 1993; Zhang et al., 1994) . Our data suggest that JAK kinases utilize JH2 domain to recognize their substrate instead of the internal substrate pocket. These data do not exclude the possibility that JAK does not phosphorylate STAT5 directly. That is, upon receptor dimerization JAK could bring STAT5 to another JAK that is adjacently located. In support of this hypothesis, it was reported recently that a mutant whose kinase domain was deleted was able to sustain STAT1 activation in response to IFNg in cells lacking endogenous JAK1 expression (Briscoe et al., 1996) . It is possible that JAK1, in the absence of its kinase activity, can act as an adaptor molecule by bringing the STAT protein to appropriate kinases.
Direct activation of STAT by JAK
In this report, using a stable and transient transfection system, we showed that either truncation of the carboxy terminal phosphorylation sites in gp130 (G-68) or point mutations lacking the phosphoacceptor sites (G-Fall), completely abolished the tyrosine phosphorylation and the induction of DNA binding activity of STAT3. STAT5, however, was tyrosine phosphorylated, and its DNA binding activity was induced by the G-68 or G-Fall chimeric receptor at the same level as was detected in G-277 transfectants (Figure 4 ). These data reveal that the membraneproximal 68 amino acid region was sucient, and that the phosphotyrosines of gp130 were not necessary for STAT5 activation. The membrane-proximal 68 amino acid region contains box 1 and box 2 and is a minimal region required to induce JAK kinase activity upon stimulation by cytokines (Narazaki et al., 1994; Fukada et al., unpublished data) . It is unlikely that unidenti®ed component(s) of the IL-6 receptor was involved in tyrosine phosphorylation of STAT5, because its tyrosine phosphorylation could be induced through the G-CSF-R chimeric receptor as well as through native IL-6 receptor (Lai et al., 1995; MT-T et al, unpublished results) . It is conclusively shown that IL-6 induces the formation of receptor complex composed of two IL-6, two IL-6 receptor a and two gp130 molecules (Paonessa et al., 1995) , excluding the possible involvement of unidenti®ed receptor subunits in STAT5 activation. Furthermore, it is well established that G-CSF induces the homodimerization of G-CSF receptor (Ikeda et al., 1993) , thus the chimeric receptor should form homodimer upon the binding of G-CSF to its extracellular domain of G-CSF receptor.
Taken together with the fact that STAT5 directly binds the JH2 domain of JAK, these results support a model in which STAT5 is activated by direct interaction with JAKs. The dierence in the activation mechanisms for STAT3 and STAT5 is thought to be caused by dierences in their binding anities for JAK1 and JAK2, and by dierences in the recognition speci®cities of their SH2 domains. The direct activation of STATs by JAK kinases has been previously demonstrated. When the chimeric molecule, CD16/JAK2 was expressed on the cell surface of Ba/F3, a STAT-like complex detected by an electrophoretic mobility shift assay was activated upon cross-linking with an anti-CD16 antibody, suggesting that under certain conditions, JAK2 directly activates STAT without activation or phosphorylation of the cytokine receptor (Sakai et al., 1995) . The binding activity of STAT5 was reported to be induced by the phosphorylation of STAT5 by JAK2 in vitro (Gouilleux et al., 1994) . Gupta et al. (1996) showed that JAK1 directly phosphorylates STAT1, by using recombinant molecules expressed by the baculovirus system. A mutation of SH2 domain of STAT1 abolished its tyrosine phosphorylation by JAK1, and they concluded that interaction of tyrosine-phosphorylated JAK1 and SH2 domain of STAT1 mediated STAT1 phosphorylation. In a yeast two-hybrid system, GAL4 DBD-JH2s cannot be tyrosine phosphorylated because of a lack of kinase activity of the JH2, therefore interaction of the JH2 with STAT5 should be dierent from the SH2-mediated interaction between JAK1 and STAT1 reported by Gupta et al. Two dierent mechanisms may cooperate to stengthen and specify their interactions.
Two distinct pathways for STAT activation
Most of STAT proteins were reported to require tyrosine phosphorylation of the cytokine receptors for their activation. For example, the tyrosine phosphorylation of STAT5 requires the tyrosine phosphorylation of the IL-2 receptor b chain and the erythropoietin receptor (Fujii et al., 1995; Friedmann et al., 1996; Frederic et al., 1996) , and STAT1, STAT2 and STAT6 have been shown to recognize and require phosphorylated tyrosine motifs on the IFNg receptor a chain (Greenlund et al., 1994) , the IFNa receptor a chain (Yan et al., 1996a) and the IL-4 receptor a chain (Hou et al., 1994) , respectively, for their activation. Whereas the GM ± CSF-induced STAT5 activation and the G-CSF-induced STAT3 activation were shown not to require the tyrosine phosphorylation of their receptors (Mui et al., 1995; Yoshikawa et al., 1995) . In the gp130 system, we observed that two STAT molecules were regulated dierently, the activation of STAT3 strictly depended on the tyrosine phosphorylation of gp130, while the STAT5 did not need phosphotyrosines on gp130. Together with the data concerning the JAK1-STAT5 interaction, STAT5 is likely activated by the direct interaction with JAKs, and the phosphorylation of STAT3 by JAKs is supported by the interaction between STAT3-SH2 and the tyrosine phosphorylated receptor (Figure 7) .
If the direct interaction between JAKs and STAT5 tightly regulates the activation of STAT5, why the tyrosine phosphorylation of STAT5 is not detected upon the stimulation of the IL-4 receptor, which is also reported to activate both JAK1 and JAK3, or why the activation of STAT5 mainly depends on the tyrosine phosphorylation of IL-2 receptor b chain and Epo receptor? There are possible explanations. Firstly the interaction between JAKs and STAT5 (as shown in Figure 2 ), or JAKs and cytokine receptors has a variety of stoichiometry. Also the stoichiometry of the interaction may depend on the amount of JAK and STAT5 proteins expressed in cells. If the association between JAK1 and a receptor is stoichiometrically not high enough even though STAT5 can interact with JAK1 relatively stongly, STAT5 may not be activated through that receptor. Secondly, if a JAK works merely as a connector for STAT5 to present it for another JAK associated with the other component of the receptor, as described above, the phosphorylation of STAT5 may depend on the structure of receptor complex. To reveal such a possibility, the structural analysis of the receptor with JAKs will be necessary.
In the cases of IL-2 receptor b chain and Epo receptor, STAT5 was shown to be still activated weakly when tyrosine-less receptors were expressed (Friedmann et al., 1996; Gobert et al., 1996) , suggesting that STAT5 can be also activated through these receptors in a manner which is independent of the tyrosine-phosphorylation of the receptors. The mutations of STAT5a with reduced anity against the JAK1-JH2, slightly diminished their tyrosine phosphorylation upon the stimulation of the Epo receptor but not as much as that upon gp130-stimulation (Figure 6c) , suggesting that the direct interaction of STAT5 with JAKs might be also involved in Epo receptor-mediated activation of STAT5. Thus two distinct mechanisms may synergistically activate STAT molecules in certain cytokine receptors. In general, we predict that the combination of the binding speci®city of JAK-JH2 for STAT, that of STAT-SH2 for the tyrosine-phosphorylated cytokine receptor, spectra of JAKs that associate with receptor, and the amount and the spectra of all these molecules expressed in a given cell eventually determines the spectra of the JAK-STAT signal transduction pathway that is activated through a given cytokine receptor in a particular cell type.
Materials and methods
Yeast two-hybrid screening and cDNA isolation
Full open reading frames of human JAK1 and murine JAK2 were subcloned in-frame into the GAL4 DNAbinding domain vector, pAS2 (a gift from Dr S Elledge; Harper et al., 1993) by using their restriction sites. Fragments JH7-3, JH2 and JH1 of JAK1 or JAK2 were ampli®ed from cDNAs encoding human JAK1 and mouse JAK2 by PCR, and cloned in-frame into the SmaI/BamHI sites of pAS2. The sequences of the primers used for PCR are available on request. The resulting plasmids were used as baits to screen a human B lymphocyte cDNA library (a gift from Dr S Elledge; Durfee et al., 1993) constructed in pACT, the GAL4 transactivation domain vector. Yeast transformation and screening procedures have been described previously (Durfee et al., 1993; Harper et al., 1993) . In brief, Saccharomyces cerevisiae Y190 cells were transformed with the bait plasmids using the modi®ed lithium acetate method (Schiestl and Gietz, 1989 ) and transformants were selected on an agar plate of synthetic dextrose medium lacking uracil and tryptophan (SD-Ura, Trp). The transformants were grown in SD-Ura, Trp medium and further transformed with 40 mg of library plasmid DNA for each transformation. Transformed yeast cells were plated on SD agar lacking uracil, tryptophan, leucine, and histidine, but containing 100 mM 3-aminotriazole (nakalai tesque) for selection, or SD agar lacking uracil tryptophan, and leucine to determine the transformation eciency. Colonies that were grown for 6 days on the selection plates were subjected to an X-gal ®lter assay to detect b-galactosidase activity. pACT library plasmids were recovered from the obtained yeast transformants and expanded in bacteria. To eliminate false positive clones, Y190 cells were co-transformed with the library plasmids and either the pAS2 mock vector or the bait plasmids, and their interactions were con®rmed by examining the bgalactosidase activity of their transformants. The strength of their association was quanti®ed by liquid b-galactosidase assay using ONPG as a substrate (Guarente, 1983) .
To obtain a longer clone for human STAT5b, a human T cell line Jurkat Zap Express cDNA library (Stratagene) was screened by the standard hybridization technique using the insert fragments of clone #JH2-14. The obtained cDNAs were subcloned into pBluescript SK + (Stratagene) and subjected to sequence analysis using Thermosequenase (Amersham) and a Pharmacia ALF automated sequencer.
To evaluate the expression of STAT proteins in yeast cells, we isolated yeast nuclei from spheroplast cells. Yeast cells were incubated in SZ buer (1 M sorbitol, 100 mM sodium citrate, 60 mM EDTA, 10 mM 2-mercaptoethanol) containing 3 mg/ml of Zymolyase at 378C for 30 min, spheroplast cells were recovered by centrifugation and lysed by 100 ml of NPB buer (10 mM TrisHCl pH 7.4, 2 mM MgCl 2 , 140 mM NaCl, 0.5 mM DTT, 0.5 mM PMSF) containing 0.1% Triton X-100. Homogenate were placed onto 100 ml of 50% sucrose/NPB and the yeast nuclei were pelleted by centrifugation. Nuclear proteins were extracted by the SDS ± PAGE loading buer and analysed by immunoblotting with anti-HA antibody.
Stable transfection, cell culture, and biological reagents An IL-3-dependent mouse pro-B cell line, BAF-B03, was maintained in RPMI 1640 medium supplemented with 100 U/ml penicillin, 100 mg/ml streptomycin, 10% fetal calf serum, and 10% conditioned medium from WEHI-3B cells as a source for IL-3.
Construction of chimeric receptors and establishment of their BAF-B03 transfectants was described previously . Transfectants were maintained in medium containing 1 mg/ml of G418. The human embryonic Figure 7 Model for STATs activation through gp130. The explanations for presented schemes are described in the text kidney cell line 293T was maintained in Dulbecco's modi®ed Eagle's medium (DMEM; Gibco) with 10% fetal calf serum and antibiotics.
Recombinant human G-CSF was provided from Chugai Pharmaceutical Co. The rabbit anti-JAK1 and JAK2 antisera were made by immunizing rabbits with peptides speci®c to each JAK (Matsuda et al., 1994) . The rabbit anti-STAT5 (MGF) antibody was a gift from Drs H Wakao and A Miyajima. The monoclonal antibody 9E10 against the Myc epitope was purchased from Genosys Biotechnologies Inc. The anti-HA epitope monoclonal antibody 12CA5 was purchased from Boehringer Mannheim Co. Ltd.
Plasmid construction
To construct a series of deletion mutants of the JH2 domain of JAK1, fragments were ampli®ed by PCR and inserted into the SmaI/BamHI sites of pAS2. Fragments of STAT5a were generated from human STAT5a cDNA (a gift from Dr S McKnight) by PCR and inserted into the SmaI/BamHI sites of pACT2. To construct an expression vector for epitope-tagged STAT5a (STAT5a-Myc) and STAT3 (STAT3-Myc), we generated a myc epitope at its carboxy terminal using PCR as described previously (Squinto et al., 1990) . The entire coding fragments of STAT5a-Myc and STAT3-Myc was excised, blunted by T4 polymerase, and ligated with BstXI adaptor (Invitrogen). pEF STAT5a-Myc and pEF STAT3-Myc were constructed by inserting the BstXI adaptor-ligand fragment into the BstXI sites of pEFBOS. The mutant expression vectors, pEF STAT5(AY)-Myc and pEF STAT5(AA)-Myc were constructed by site-directed mutagenesis using a two step PCR protocol (Higuchi et al., 1988) . To construct an HAtagged JAK1 expression vector, the entire coding fragment of human JAK1 was subcloned into pBluescript3xHA-JNK1, which was constructed from SRa3xHA-JNK1 (DeÂ rijard et al., 1994) . pEF HA-JAK1 was obtained by subcloning the entire coding fragment of HA-tagged JAK1 into the BstXI sites of pEFBOS after blunting and BstXI adaptor ligation. All the PCR reactions were performed using Pfu polymerase (Stratagene). DNA fragments obtained by PCR were con®rmed by sequencing.
In vivo and in vitro association 293T cells grown subcon¯uently (750%) in a 10 cm dish were transfected with 10 mg of either pEF HA-JAK1, pEF STAT5a-Myc, pEF STAT3-Myc, or their combination, using a standard calcium phosphate precipitation method (Sambrook et al., 1989) . Seventy-two hours after transfection, cells were harvested and lysed in lysis buer A: 50 mM TrisHCl (pH 7.5), 150 mM NaCl, 1 mM PMSF, 1% digitonin, 1 mg/ml aprotinin, and 1 mg/ml leupeptin. Lysates were cleared by 10 000 g ultracentrifugation at 48C for 30 min and mixed with 10 ml of protein A sepharose (Pharmacia) and either 1 mg of anti-HA antibody (12CA5) or 1 mg of anti-Myc antibody (9E10), followed by 8 h of incubation at 48C. The beads were washed ®ve times with 1 ml of the lysis buer in the absence of protease inhibitors. The immunoprecipitates were eluted with Laemli's SDS loading buer, separated on a 4 ± 20% SDS-polyacrylamide gradient gel and transferred to a PVDF membrane Immobilon P (Millipore). The membranes were incubated with either 0.1 mg/ml of anti-HA antibody or 0.1 mg/ml anti-Myc antibody for 1 h at room temperature, washed three times with TBST: 20 mM TrisHCl (pH 7.4), 150 mM NaCl, 0.1% Tween 20, then incubated with 2000 times diluted horseradish peroxidaseconjugated goat anti-mouse antibody (TAGO) for 1 h. After washing with TBST, the immune complex was visualized using a chemiluminescence system (Renaissance, DuPont, NEN).
For in vitro binding, the JH2 domains of JAK1 and JAK2 were ampli®ed from pEF JAK1 (human) and pEF JAK2 (mouse) by PCR and cloned in-frame into the BamHI/SmaI sites of pGEX3X (Pharmacia). The expression and purification of GST-JAK1JH2 and GST-JAK2JH2 fusion proteins were carried out as described (Smith and Johnson, 1988) . Lysate (approximately equivalent to 200 mg protein) prepared in lysis buer B: 50 mM TrisHCl (pH 7.5), 150 mM NaCl, 1 mM PMSF, 0.1% NP40, 1 mg/ml aprotinin, 1 mg/ml leupeptin, from a 10 cm dish of 293T cells transfected with pEF STAT5a-Myc or pEF STAT3-Myc, was mixed with 10 mg of GST-, GST-JAK1JH2-, or GST-JAK1JH2-bound 10 ml glutathione-conjugated sepharose (Pharmacia) and incubated for 8 h at 48C. The beads were washed extensively with 1 ml lysis buer, ®ve times. The bound proteins were eluted and subjected to SDS-polyacrylamide gel electrophoresis. Proteins were transferred to a PVDF membrane, and the bound STAT proteins were detected with anti-Myc antibody.
Electrophoretic mobility shift assay
Nuclear extracts were prepared as described previously (Sadowski et al., 1993) . The TB2 (Lai et al., 1995) doublestranded oligonucleotide was end-labeled with [a-32 P]dCTP using the Klenow fragment of DNA pol1. The TB2 sequence used is as follows: 5'-TCGACATCCTTCTGGGAATTCT-GATCCTTCTGGGAATTCTGGGTAC-3'. Binding reactions contained 12 mM HEPES (pH 7.9), 50 mM NaCl, 1 mM EDTA, 1 mM DTT, 10% glycerol, 30 000 c.p.m. of end-labeled oligonucleotide and 10 mg of nuclear extract. 1.5 mg of poly(dI-dC) (Pharmacia) was used as a nonspeci®c competitor. After a 10 min incubation at 378C for binding, the protein-DNA complexes were resolved by electrophoresis on a 4.5% polyacrylamide gel containing 2.5% glycerol in 0.256TBE (25 mM Tris, 25 mM bolic acid, 0.5 mM EDTA) and visualized by autoradiography. The bound fraction was quanti®ed using a BAS2000 image analyser (Fuji).
